ReviewInternational journal of women's health2013

Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast.

Lin H Soe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.